Facts & Figures

Facts

Year of Foundation: 1946

Shareholder Structure 2010: 19 shareholders

Group Operating Committee:

Corporate Officers:

  • Harald F. Stock, PhD., Chief Executive Officer, Chairman of the Corporate Management Board
  • Prof. Dr. Eric-Paul Pâques, President Grünenthal Innovation & Chief Alliance Officer, Vice-Chairman of the Corporate Management Board
  • Stefan Genten, Chief Financial Officer & Chief Operating Office

Heads of the Strategic Business Units and Functions:

  • Alberto Grua, PhD., Executive Vice President Grünenthal Europe & Australia
  • Klaus D. Langner, PhD., Executive Executive Vice President and Chief Operating Officer of Grünenthal Innovation
  • Jan Van Ruymbeke, M.D., Executive Vice President Grünenthal Latin America
  • Thomas Senderovitz, M.D., Executive Vice President Compound Development & Branding
  • Heinz-Gerd Suelmann, PhD., Executive Vice President Global Human Resources

Supervisory Board 2010: 5 members

International Presence 2010: Affiliates in 30 countries worldwide, 5 production sites, headquarters Aachen Germany

Main Business Areas 2010: Pain

Top-Selling Products (Global Brands 2010):  Palexia®, Zaldiar®, Tramal®, Transtec®, Norspan®, Versatis®

Figures

Corporate Figures in Mio € 2010 2009
Revenues 910 881
Revenue Growth vs. Previous Year 3% 2%
Growth Pain Business1 + 6.8% + 4.7%
   Growth Pain Business Europe2 + 6.6% + 4.7%
Revenues by regions    
    Europe 700 706
   Latin America 133 143
   Rest of world 78 31
Operating Sales net by main products 860 843
   Global Brands Pain 472 443
      Palexia® 4 0
      Zaldiar® 167 146
     Tramal® 137 147
     Transtec® / Norspan® 123 123
     Versatis® 41 27
   Other Global Brands 88 101
      Belara® 65 77
      Colistin / Colistin CF 23 24
   Local / Regional Products 300 299
Research & Development Costs 207 157
R&D Costs Ratio (R&D Costs / Revenues) 23% 18%
Income before Taxes (IBT) 344 116
Return on Revenue (IBT / Revenue) 38% 13%
Equity Ratio 66% 58%
Employees (annual average) ca. 4,900 ca. 5,000

Our financial statements are published at www.ebundesanzeiger.de (German)
1 Grunenthal's Pain Business excl. partner franchise in Grunenthal countries (acc. IMS)
2 Grunenthal's Pain Business Europe excl. partner franchise in Grunenthal countries (acc. IMS)